Gene expression profiling of non-alcoholic steatohepatitis using gene set enrichment analysis

Hepatology Research

Volumn 38, Issue 12, 2008, Pages 1204-1212

  Yoneda, Masato ^a   Endo, Hiroki ^a   Mawatari, Hironori ^a   Nozaki, Yuichi ^a   Fujita, Koji ^a   Akiyama, Tomoyuki ^a   Higurashi, Takuma ^a   Uchiyama, Takashi ^a   Yoneda, Kyoko ^a   Takahashi, Hirokazu ^a   Kirikoshi, Hiroyuki ^a   Inamori, Masahiko ^a   Abe, Yasunobu ^a   Kubota, Kensuke ^a   Saito, Satoru ^a   Kobayashi, Noritoshi ^a   Yamaguchi, Naotaka ^b   Maeyama, Shiro ^c   Yamamoto, Shogo ^d   Tsutsumi, Shuichi ^d   Aburatani, Hiroyuki ^d   Wada, Koichiro ^e   Hotta, Kikuko ^f   Nakajima, Atsushi ^a   more..

^a YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Kitakashiwa Rehabilitation Hospital   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^f SNP Research Center   (Japan)

Author keywords

Gene set enrichment analysis; Microarray; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis

Indexed keywords

MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; DNA PROBE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SET ENRICHMENT ANALYSIS; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PRIORITY JOURNAL; VALIDATION PROCESS;

EID: 55449094777     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00399.x     Document Type: Article

References (59)

1. Angulo P. Non-alcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
2. Farrell GC. Non-alcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003; 18: 124-38.
3. Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in non-alcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95: 1056-62.
4. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-10.
5. Day CP, James OF. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998; 114: 842-5.
6. Chitturi S, Abeygunasekera S, Farrell GC et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-9.
7. Sanyal AJ, Campbell-Sargent C, Mirshahi F et al. Non-alcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-92.
8. Cortez-Pinto H, Chatham J, Chacko VP et al. Alterations in liver ATP homeostasis in human non-alcoholic steatohepatitis: A pilot study. JAMA 1999; 282: 1659-64.
9. Rashid A, Wu TC, Huang CC et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 1999; 29: 1131-8.
10. Yang SQ, Lin HZ, Mandal AK et al. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: Implications for non-alcoholic fatty liver disease pathophysiology. Hepatology 2001; 34: 694-706.
11. Soltys K, Dikdan G, Koneru B. Oxidative stress in fatty livers of obese Zucker rats: Rapid amelioration and improved tolerance to warm ischemia with tocopherol. Hepatology 2001; 34: 13-18.
12. Marshall A, Hodgson J. DNA chips: An array of possibilities. Nat Biotechnol 1998; 16: 27-31.
13. Hippo Y, Taniguchi H, Tsutsumi S et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 2002; 62: 233-40.
14. Dennis G Jr, Sherman BT, Hosack DA et al. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3.
15. Doniger SW, Salomonis N, Dahlquist KD et al. MAPPFinder: Using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 2003; 4: R7.
16. Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-7.
17. Sreekumar R, Rosado B, Rasmussen D et al. Hepatic gene expression in histologically progressive non-alcoholic steatohepatitis. Hepatology 2003; 38: 244-51.
18. Younossi ZM, Gorreta F, Ong JP et al. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int 2005; 25: 760-71.
19. Mootha VK, Lindgren CM, Eriksson KF et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-73.
20. Sanyal AJ. AGA technical review on non-alcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-25.
21. Matteoni CA, Younossi ZM, Gramlich T et al. Non-alcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-19.
22. Brunt EM. Non-alcoholic steatohepatitis: Definition and pathology. Semin Liver Dis 2001; 21: 3-16.
23. Yoshizumi T, Nakamura T, Yamane M et al. Abdominal fat: Standardized technique for measurement at CT. Radiology 1999; 211: 283-6.
24. Su AI, Cooke MP, Ching KA et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 2002; 99: 4465-70.
25. Subramanian A, Tamayo P, Mootha VK et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-50.
26. Sano H, Sudo T, Yokode M et al. Functional blockade of platelet-derived growth factor receptor-beta but not of receptor-alpha prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation 2001; 103: 2955-60.
27. Hart CE, Kraiss LW, Vergel S et al. PDGFbeta receptor blockade inhibits intimal hyperplasia in the baboon. Circulation 1999; 99: 564-9.
28. Boucher P, Gotthardt M, Li WP et al. LRP: Role in vascular wall integrity and protection from atherosclerosis. Science 2003; 300: 329-32.
29. Gouilleux F, Wakao H, Mundt M et al. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J 1994; 13: 4361-9.
30. Levy DE, Darnell JE Jr. Stats: Transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002; 3: 651-62.
31. Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol 2001; 13: 211-17.
32. Nelms K, Keegan AD, Zamorano J et al. The IL-4 receptor: Signaling mechanisms and biologic functions. Annu Rev Immunol 1999; 17: 701-38.
33. Warren WD, Berton MT. Induction of germ-line gamma 1 and epsilon ig gene expression in murine B cells. IL-4 and the CD40 ligand-CD40 interaction provide distinct but synergistic signals. J Immunol 1995; 155: 5637-46.
34. Rengarajan J, Szabo SJ, Glimcher LH. Transcriptional regulation of Th1/ Th2 polarization. Immunol Today 2000; 21: 479-83.
35. Costa RH, Grayson DR, Darnell JE Jr. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes. Mol Cell Biol 1989; 9: 1415-25.
36. Lai E, Prezioso VR, Smith E et al. HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev 1990; 4: 1427-36.
37. Lai E, Prezioso VR, Tao WF et al. Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head. Genes Dev 1991; 5: 416-27.
38. Iamaroon A, Pattamapun K, Piboonniyom SO. Aberrant expression of Smad4, a TGF-beta signaling molecule, in oral squamous cell carcinoma. J Oral Sci 2006; 48: 105-9.
39. Lagna G, Hata A, Hemmati-Brivanlou A etal. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 1996; 383: 832-6.
40. Zhao GQ, Eberspaecher H, Seldin MF et al. The gene for the homeodomain-containing protein Cart-1 is expressed in cells that have a chondrogenic potential during embryonic development. Mech Dev 1994; 48: 245-54.
41. Qu S, Li L, Wisdom R. Alx-4: cDNA cloning and characterization of a novel paired-type homeodomain protein. Gene 1997; 203: 217-23.
42. Grundemann D, Gorboulev V, Gambaryan S et al. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994; 372: 549-52.
43. Kappeler SR, Farah Z, Puhan Z. 5′-flanking regions of camel milk genes are highly similar to homologue regions of other species and can be divided into two distinct groups. J Dairy Sci 2003; 86: 498-508.
44. Bailey SM, Patel VB, Young TA et al. Chronic ethanol consumption alters the glutathione/glutathione peroxidase-1 system and protein oxidation status in rat liver. Alcohol Clin Exp Res 2001; 25: 726-33.
45. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002; 23: 824-54.
46. Lewitt MS. Role of the insulin-like growth factors in the endocrine control of glucose homeostasis. Diabetes Res Clin Pract 1994; 23: 3-15.
47. Mortensen DL, Won WB, Siu J et al. Insulin-like growth factor binding protein-1 induces insulin release in the rat. Endocrinology 1997; 138: 2073-80.
48. Leu JI, Crissey MA, Taub R. Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. J Clin Invest 2003; 111: 129-39.
49. Degenhardt T, Matilainen M, Herzig KH et al. The insulin-like growth factor-binding protein 1 gene is a primary target of peroxisome proliferator-activated receptors. J Biol Chem 2006; 281: 39607-19.
50. Boyd JM, Malstrom S, Subramanian T et al. Adenovirus E1B 19kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 1994; 79: 341-51.
51. Churchill GA. Fundamentals of experimental design for cDNA microarrays. Nat Genet 2002; 32: 490-5.
52. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001; 98: 31-6.
53. Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002; 32 (Suppl): 496-501.
54. Tusher VG, Tibshirani R, Chu G et al. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-21.
55. Eisen MB, Spellman PT, Brown PO et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-8.
56. Tamayo P, Slonim D, Mesirov J et al. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 1999; 96: 2907-12.
57. Tavazoie S, Hughes JD, Campbell MJ et al. Systematic determination of genetic network architecture. Nat Genet 1999; 22: 281-5.
58. Hosack DA, Dennis G Jr, Sherman BT et al. Identifying biological themes within lists of genes with EASE. Genome Biol 2003; 4: R70.
59. Vissinger H, Husted SE, Kristensen SD et al. Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid. Angiology 1993; 44: 633-8.